Ab4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).
Buy AB4AD (Antibodies for Alzheimer's Disease)Earn up to $2,000 when you buy $50 in crypto
Sign me up
2
$158.82K
4.78%
$158.82K
1M AB4AD
1M AB4AD
1M AB4AD
$166.37K
Not enough data
0%
$416.07
-100%
Not enough data
Not enough data
$0.17
-75.44%
AB4AD vs markets
↘ 86.07%
AB4AD vs BTC
↘ 86.11%
AB4AD vs ETH
↘ 84.77%
Tags
Network | Address | |
|---|---|---|
Base | 0x57414656AC535680367f519eeC9f0D7Ffe99e2D0 |
Time | Price | Change |
|---|---|---|
Today | $0.17 | ↗ 4.78% |
1 Day | $0.16 | ↗ 4.78% |
1 Week | $0.33 | ↘ 49.92% |
1 Month | $0.52 | ↘ 68.19% |
1 Year | $0.68 | ↘ 75.44% |
The latest AB4AD price is $0.17. Compared to AB4AD (Antibodies for Alzheimer's Disease)'s value of $0.16 from 24 hours ago, there's been a 5% increase, while the current price is -50% down from $0.33 which was recorded one week ago. AB4AD (Antibodies for Alzheimer's Disease)'s all time high is $0.17, which was reached on September 24, 2025. This is a -0% change from its price today.
The current circulating supply of AB4AD (Antibodies for Alzheimer's Disease) is 1,000,000. This is 100% of its max supply of 1,000,000 AB4AD and 100% of its total supply of 1,000,000. The market cap is currently $158.82K, which is a result of multiplying the current price of AB4AD (Antibodies for Alzheimer's Disease)($0.17) by the total supply(1,000,000 AB4AD). The fully diluted valuation of AB4AD (Antibodies for Alzheimer's Disease) is $158.82K. The diluted valuation of AB4AD (Antibodies for Alzheimer's Disease) is $158.82K.
We update our AB4AD (Antibodies for Alzheimer's Disease) to USD currency in real-time. Get the live price of AB4AD (Antibodies for Alzheimer's Disease) on Coinbase.
The current market cap of AB4AD (Antibodies for Alzheimer's Disease) is $158.82K. A high market cap implies that the asset is highly valued by the market.
The all-time high of AB4AD (Antibodies for Alzheimer's Disease) is $0.17. This all-time high is highest price paid for AB4AD (Antibodies for Alzheimer's Disease) since it was launched.
Over the last 24 hours, the trading volume of AB4AD (Antibodies for Alzheimer's Disease) is $416.07.
Assets that have a similar market cap to AB4AD (Antibodies for Alzheimer's Disease) include Dentacoin, NEUY, YIN Finance, and many others. To see a full list, see our comparable market cap assets.
The current circulating supply of AB4AD (Antibodies for Alzheimer's Disease) is 1 million.
Earn up to $2,000 when you buy $50 in crypto
Earn free crypto after making your first purchase.
Terms apply. Sum of median estimated savings and rewards earned, per user in 2021 across multiple Coinbase programs (excluding sweepstakes). This amount includes fee waivers from Coinbase One (excluding the subscription cost), rewards from Coinbase Card, and staking rewards.
Information is provided for informational purposes only and is not investment advice. This is not a recommendation to buy or sell a particular digital asset or to employ a particular investment strategy. Coinbase makes no representation on the accuracy, suitability, or validity of any information provided or for a particular asset.
Certain content has been prepared by third parties not affiliated with Coinbase Inc. or any of its affiliates and Coinbase is not responsible for such content. Coinbase is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Information is provided for informational purposes only and is not investment advice. This is not a recommendation to buy or sell a particular digital asset or to employ a particular investment strategy. Coinbase makes no representation on the accuracy, suitability, or validity of any information provided or for a particular asset. Prices shown are for illustrative purposes only. Actual cryptocurrency prices and associated stats may vary. Data presented may reflect assets traded on Coinbase’s exchange and select other cryptocurrency exchanges.
